Network meta-analysis of 99 RCTs in rheumatoid arthritis: JAK inhibitors (HAQ MD −0.13) and IL-6 inhibitors (MD −0.13) reduced activity limitation more than TNF inhibitors; no other significant class differences in pain, fatigue or physical or mental health.
Meta-analysisn = 99 trials
van Esveld et al. Effects of biologic and targeted synthetic disease modifying antirheumatic drugs (b/tsDMARDs) on patient-reported outcome domains in rheumatoid arthritis: a systematic review and network meta-analyses